Listen to today’s podcast!
A recent study has found that the total daily dose method for predicting starting basal insulin pump rates is effective in both type 1 and type 2 diabetes.
Researchers from the University of British Columbia completed this study using 95 patients with diabetes on continuous subcutaneous insulin infusion therapy – 61 had type 1 diabetes and 34 had type 2 diabetes. The total daily dose method was compared to empirical estimates, the regression formula, and the weight-based method. The regression formula was found to be more accurate with type 2 diabetes. However, the total daily dose method of estimation was found to be safer.
The study also emphasized that a medical professional’s judgment will be needed to determine the starting basal rates, as all of the possible methods have their shortcomings.
These findings were published in BMJ Open Diabetes Research & Care on March 1, 2016.